Alfonso Luis de Oyarzabal Sanz

Investigador

Research group

Díaz-Osorio Y, Gimeno-Agud H, Marí-Vico R, Illescas KS, Ramos JM, Darling A, Garcia-Cazorla A and De Oyarzabal-Sanz AL Spermidine Recovers the Autophagy Defects Underlying the Pathophysiology of Cell Trafficking Disorders JOURNAL OF INHERITED METABOLIC DISEASE 2025. 48(1): .
Gimeno-Agud H, Díaz-Osorio Y and De Oyarzabal-Sanz AL Biological Basis of Cell Trafficking: A General Overview. JOURNAL OF INHERITED METABOLIC DISEASE 2025. 48(1): .
Julià-Palacios NA, Olivella M, Sigatullina M, Ibáñez-Micó S, Muñoz-Cabello B, Alonso-Luengo O, Soto-Insuga V, García-Navas D, Cuesta-Herraiz L, Andreo-Lillo P, SERGIO AGUILERA ALBESA, Hedrera-Fernández A, González Alguacil E, Sánchez-Carpintero R, Martín Del Valle F, Jiménez González E, Cean Cabrera L, Medina-Rivera IF, Pérez M, Colomé-Roura R, Lopez L, Engracia Cazorla M, Fornaguera M, Ormazabal-Herrero A, Alonso-Colmenero I, Illescas KS, Balsells S, Marí-Vico R, Maria Duffo Viñas, Cappuccio G, Terrone G, Romano R, Manti F, Mastrangelo M, Alfonsi C, de Siqueira Barros B, Nizon M, Gjerulfsen CE, L Muro V, Karall D, Zeiner F, Masnada S, Peterlongo I, De Oyarzabal-Sanz AL, Santos-Gómez A, Altafaj X and Garcia-Cazorla A L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized study BRAIN 2024. 147(5): 1653-1666.

More Publications

Project name:: Modelos experimentales de sinaptopatías aplicados a la medicina personalizada de trastornos genéticos raros de la comunicación neuronal neuropediátricos
Leader: MªAngels García Cazorla
Funding entities:: Instituto de Salud Carlos III (ISCIII)
Code: PI24/00469
Starting - finishing date:: 2024 - 2027

Project name:: Enfermedad es Bpan
Leader: Alejandra Darling , Alfonso Luis De Oyarzabal Sanz
Funding entities:: ZZZZ_O.H.S.J.D.-Curia Provincial, Provincia San Juan de Dios de España
Code: PFNR0186
Starting - finishing date:: 2023 - 2025

Project name:: Entrega de MeCP2 en el cerebro mediante el uso de nanocápsulas para el tratamiento del síndrome de Rett
Leader: Alfonso Luis De Oyarzabal Sanz
Funding entities:: Generalitat de Catalunya
Code: SLT033/23/000097
Starting - finishing date:: 2023 - 2024

More projects

Advances in Research on Rett Syndrome
Friday, 24 November 2023
A study conducted by the Paediatric Neurometabolic Disorders: Neural Communication Mechanisms and Personalised Therapies Group at IRSJD · SJD Barcelona Children's Hospital confirms mitochondrial dysfunction in two distinct models of Rett syndrome, highlighting the significance of distinguishing between brain regions and stages of the disease. The findings of this study open up new avenues for treatment development.

See All news

More activities